Articles | Open Access | https://doi.org/10.55640/

HYPERTENSION TO NORMALIZE HEMODYNAMICS OF PERINDOPRIL AND IVABRADINE

Yarmatov Suvon Tatlibayevich,Muzaffarova Malika Sho’hratovna,Ollaev Ilhom Bahriddinovich,Axtamova Shirin Xayrulloevna,Kattabekov Ozodbek Oybekovich,Xushvaqtova Zuhraoy Berdiqulovna , Samarkand State Medical University

Abstract

Evaluation of the diastolic properties of the left ventricular myocardium (LV) in patients with hypertensive heart is relevant due to the fact that they, forming against the background of an increase in LV myocardial mass, are able to progress, manifesting clinical syndrome of chronic heart failure mainly in old age. The aim is to determine the effectiveness of perindopril and ivabradine in correcting blood pressure and heart rate, as well as functional parameters of LV myocardium, vasoregulatory function of peripheral arterial endothelium in patients with hypertension. Object and methods. The study included 43 men aged 52 to 64 years with a diagnosis of hypertension without systematic use of antihypertensive drugs in the past, who did not have clinical signs of chronic heart failure, with a sinus rhythm at rest of more than 75 per minute. The control group consisted of 21 men, comparable in age, without abnormalities on electrocardiography and physical signs of heart disease. All patients included in the study underwent an echocardiographic examination, which determined the main parameters at rest. Pulse-wave Dopplerography of the LV inflow pathway was also used, and in the tissue dopplerography mode, the speed of movement of the lateral part of the mitral valve ring and the LV myocardial productivity index were evaluated. Load testing was carried out on a bicycle ergometer for 2 minutes with a power of 25, 50 and 75 watts. Endothelial function and stiffness systemic arteries were assessed by finger computed photoplethysmography. The study was divided into 3 visits: on the 1st, patients were prescribed perindopril at a dose of 10 mg / day; on the 2nd, ivabradine was added at a dose of 7.5 mg 2 times a day for a month; the 3rd visit was the final stage of the study. Results. According to blood pressure measurements at the last visit, the group of patients with hypertension did not differ from the control group in systolic and diastolic pressure while lying, sitting, and at a load of 25 watts. The addition of ivabradine to perindopril increased the bradycardic effect significantly equalized the group of patients with the control heart rate in the entire range of physiological conditions. The index of peripheral arterial endothelial function completely returned to normal during the follow-up. When studying the LV myocardial performance index, we have shown that performing physical activity and changing body position can significantly influence its increase in both healthy and hypertensive heart patients. Conclusion. A significant hypotensive effect of perindopril at rest, under dynamic load, and the effectiveness of ivabradine in normalizing heart rate have been demonstrated. The high sensitivity of the LV phase myocardial index as a marker of left ventricular dysfunction, dynamic changes in the index in response to normalization of blood pressure and pulse regardless of LV myocardial mass, as well as the possibility of normalization of the vasomotor function of the vascular endothelium of peripheral arteries, which creates the basis for improving the parameters of vascular rigidity in the future.

Keywords

diastolic dysfunction, phase myocardial index, chronic heart failure, perindopril, ivabradine.

References

Хамраева, Н. А., Султонов, И. И., & Хасанов, Ф. Ш. У. (2019). Кожные проявления у больных системной красной волчанкой. Вопросы науки и образования, (28 (77)), 128-131.

Sultonov, I. I., Kh, Z. S., Ruzybakieva, M. R., Kireev, V. V., Aripova, T. U., & Suyarov, A. A. (2021). Pharmacogenetic Aspects of Drug Resistance in Rheumatoid Arthritis. Annals of the Romanian Society for Cell Biology, 4147-4150.

Тоиров, А. Э., Султонов, И. И., & Тоиров, Э. С. (2020). ЗНАЧЕНИЕ ДИСФУНКЦИИ ПОЧЕК У БОЛЬНЫХ ОСТРЫМ ИНФАРКТОМ МИОКАРДА НА ФОНЕ САХАРНОГО ДИАБЕТА 2-ГО ТИПА. Вестник науки и образования, (9-3 (87)), 86-91.

Kireev, V. V., & Sultonov, I. I. (2021). Genetic Engineered Preparations-An Innovative Approach in the Treatment of Rheumatoid Arthritis. Annals of the Romanian Society for Cell Biology, 4114-4119.

Hamraeva, N. A., Sultonov, I. I., & Hasanov, F. S. (2020). Systemic lupus erythematosus treatment strategy. Journal of Critical Reviews, 7(9), 269-270.

Иргашева, У. З., Султонов, И. И., & Тоиров, Д. Р. (2013). Признаки дебюта системной красной волчанки. Академический журнал Западной Сибири, 9(1), 15-15.

Xasanov, F. S., & Sultonov, I. I. (2023). RHEUMATOID ARTHRITIS TREATED WITH DMARDS AND CARDIOVASCULAR DISEASE RISK. Oriental Journal of Medicine and Pharmacology, 3(02), 45-52.

Sultonov, I. I., Xasanov, F. S., Eshmuratov, S., Uralov, R. S., Shukurova, D., & Ziyadullayev, S. X. Predictors of Systemic Lupus Erythematosus: A Case-control Study. International journal of health sciences, 6(S10), 175-182.

Sultonov, I. I., Khamrayev, X. X., & Xasanov, F. SYSTEMIC LUPUS ERYTHEMATOSUS AND CARDIOVASCULAR PATHOLOGY: WHERE WE AT?.

Ziyadullaev, S. K., Sultonov, I. I., Dushanova, G. A., & Akbarovna, K. S. (2021). The Effectiveness Of Pharmacotherapy For Dmards With Ra Depending On The C3435t Polymorphism Of The Mdr1 Gene. Int. J. of Aquatic Science, 12(3), 2908-2916.

Islomovich, S. I., Alisherovna, K. M., & Djamshedovna, K. D. (2024). FACTORS OF OSTEOPOROSIS IN PATIENTS WITH CORONARY HEART DISEASE IN COMBINATION WITH RHEUMATOID ARTHRITIS. Ta'lim innovatsiyasi va integratsiyasi, 31(2), 132-138.

Islomovich, S. I. (2024). FEATURES OF THE COURSE OF PREGNANCY IN RHEUMATOID ARTHRITIS. International journal of medical sciences, 4(10), 77-84.

Alisherovna, K. M., Nizamitdinovich, K. S., & Islomovich, S. I. (2024). THERAPY OF RHEUMATOID ARTHRITIS DURING PREGNANCYTHE. Ta'lim innovatsiyasi va integratsiyasi, 31(2), 172-180.

Ilkhom, S. (2023). CAJAM–VOLUME 1. ISSUE 1. 2023. Central Asian Journal of Advanced Medicine, 1(01), 16-19.

Islomovich, S. I. (2024). GENDER CHARACTERISTICS OF THE CURRENT RHEUMATOID ARTHRITIS. International journal of medical sciences, 4(10), 3-8.

Djamshedovna, K. D., Alisherovna, K. M., & Islomovich, S. I. (2024). ARTERIAL HYPERTENSION IN RHEUMATOID ARTHRITIS. Ta'lim innovatsiyasi va integratsiyasi, 31(2), 139-145.

Nizamitdinovich, K. S., Alisherovna, K. M., & Islomovich, S. I. (2024). CLINICAL COURSE OF BRONCHIAL ASTHMA IN PATIENTS WITH THYROID DISEASES. Ta'lim innovatsiyasi va integratsiyasi, 31(2), 181-187.

Alisherovna, K. M., Nizamitdinovich, K. S., & Islomovich, S. I. (2024). FEATURES OF BONE MINERAL DENSITY IN PATIENTS WITH DISEASES OF THE DIGESTIVE SYSTEM. Ta'lim innovatsiyasi va integratsiyasi, 31(2), 162-171.

Alisherovna, K. M., Islomovich, S. I., & Djamshedovna, K. D. (2024). PSYCHOEMOTIONAL STATE AND QUALITY OF LIFE IN PATIENTS WITH SYSTEMIC LUPUS ERYTHEMATOSUS. Ta'lim innovatsiyasi va integratsiyasi, 31(2), 124-131.

Yarmatov, S., Khusainova, M., & Djabbarova, N. (2023). STUDY OF QUALITY OF LIFE INDICATORS IN PATIENTS WITH CORONARY HEART DISEASE USING THE SF-36 QUESTIONNAIRE. Бюллетень студентов нового Узбекистана, 1(7), 58-64.

Khusainova, M. A., & Yarmatov, S. T. (2021). CARDIAC ARRHYTHMIAS AND CARDIOHEMODYNAMIC DISORDERS IN PATIENTS VIRAL CIRRHOSIS OF THE LIVER. Scientific progress, 2(2), 196-202.

Buribayevich, N. M., & Tatlibayevich, Y. S. (2023). DIABETES MELLITUS IN COMBINATION WITH CORONARY HEART DISEASE. World Bulletin of Public Health, 27, 42-47.

Yarmatov, S. T., & Xusainova, M. A. (2021). BRONXIAL ASTMA MAVJUD BO’LGAN BEMORLARDA GASTROEZOFAGIAL REFLYUKS KASALLIGI DIAGNOSTIKASI VA OLIB BORISH ALGORITMI. Scientific progress, 2(2), 208-213.

Yarmatov, S. T. (2021). Yurak Ishemik Kasalligi Va Bachadon Miomasi Bo'lgan Bemorlarni Davolashda Antikougulyant Va Antitrombositar Terapiyani O’tkazish Bo’yicha Klinik Kuzatuvni Olib Borish. Scientific progress, 2(3), 792-797.

Yarmatov, S. T., & Yarmahammadov, U. K. (2022). Semizlik–Zamonaviy Tibbiyotda Dolzarb Muammo Sifatida Qolmoqda. Scientific progress, 3(4), 1196-1203.

Totlibayevich, Y. S., Isroilovna, I. S., & Bakirovich, K. J. (2023). CARDIAC ARRHYTHMIAS IN RHEUMATOID ARTHRITIS. Spectrum Journal of Innovation, Reforms and Development, 21, 121-127.

Khabibovna, Y. S., Alisherovna, K. M., Totlibayevich, Y. S., & Davranovna, M. K. (2023). PAINLESS CARDIAC ISCHEMIA AND RHEUMATOID ARTHRIT. Journal of new century innovations, 29(1), 98-105.

Yarmatov, S. T., & Xusainova, M. A. (2021). Yurak Ishemik Kasalligi Mavjud Bo’lgan Bemorlarda. Scientific progress, 2(3), 785-791.

Totlibayevich, Y. S., Alisherovna, K. M., Rustamovich, T. D., & Xudoyberdiyevich, G. X. (2023). Quality of Life in the Pathology of the Cardiovascular System. Miasto Przyszłości, 33, 222-228.

Alisherovna, K. M., Tatlibayevich, Y. S., Toshtemirovna, E. M. M., & Nizamitdinovich, H. S. (2021). Diagnostic Significance Daily Monitoring of Blood Pressure in Young Women (Under 40 Years Old) with Arterial Hypertension. Central Asian Journal of Medical and Natural Science, 2(5), 461-465.

Tatlibayevich, Y. S. (2024). FACTORS OF INFLAMMATION IN PATIENTS WITH ARTERIAL HYPERTENSION AND DIABETES MELLITUS. Spectrum Journal of Innovation, Reforms and Development, 24, 46-53.

Khabibovna, Y. S., Alisherovna, K. M., Nizamitdinovich, K. S., & Totlibayevich, Y. S. (2023). Features of heart failure in patients with thyrotoxicosis. Journal of new century innovations, 29(1), 89-97.

Khabibovna, Y. S., Alisherovna, K. M., Tashtemirovna, E. M. M., Totlibayevich, Y. S., Nizamitdinovich, K. S., & Baxtiyorovich, U. J. (2023). DIAGNOSTIC VALUE OF CYSTATIN C IN PATIENTS WITH HYPERTENSION AND OBESITY. World Bulletin of Public Health, 22, 55-59.

Totlibayevich, Y. S., Alisherovna, K. M., Xudoyberdiyevich, G. X., & Toshtemirovna, E. M. M. (2022). Risk Factors for Kidney Damage in Rheumatoid Arthritis. Texas Journal of Medical Science, 13, 79-84.

Toshtemirovna, E. M. M., Alisherovna, K. M., Totlibayevich, Y. S., & Muxtorovna, E. M. (2022). Hearts In Rheumatoid Arthritis: The Relationship With Immunological Disorders. Spectrum Journal of Innovation, Reforms and Development, 4, 34-41.

Toshtemirovna, E. M. M., Alisherovna, K. M., Totlibayevich, Y. S., & Duskobilovich, B. S. (2022). THE VALUE OF XANTHINE IN CHRONIC HEART FAILURE. Spectrum Journal of Innovation, Reforms and Development, 4, 24-29.

Mamasoliyevna, D. N., Alisherovna, K. M., & Totlibayevich, Y. S. (2023). Diabetes Mellitus and Non-Alcoholic Fatty Liver Disease: the Facets of Conjugacy. Miasto Przyszłości, 35, 166-173.

Alisherovna, K. M., Totlibayevich, Y. S., Davranovna, M. K., & Erkinovna, K. Z. (2022). ASSESSMENT OF THE GENERAL CONDITION AND QUALITY OF LIFE OF WOMEN POST-PRODUCTIVE AGE, WHO SUFFERED FROM COVID-19 ASYMPTOMATICALLY, AND 12 MONTHS AFTER THE MODERATE SEVERE FORM OF THE DISEASE. Spectrum Journal of Innovation, Reforms and Development, 10, 277-282.

ALISHEROVNA, M. K., SHAXMAXMUDOVNA, S. Z., & TATLIBAYEVICH, Y. S. (2021). Effectiveness of Treatment of Chronic Heart Disease Insufficiency Depending on the Functional State of the Kidneys. JournalNX, 7(02), 240-333.

Article Statistics

Downloads

Download data is not yet available.

Copyright License

Download Citations

How to Cite

HYPERTENSION TO NORMALIZE HEMODYNAMICS OF PERINDOPRIL AND IVABRADINE. (2024). International Journal of Medical Sciences, 4(11), 163-170. https://doi.org/10.55640/